DEVELOPMENT OF THE RXR AGONIST IRX4204 TO TREAT MULTIPLE SCLEROSIS AND OTHER IMMUNE RELATED DISEASES

Project Number

2R44AI112512-02A1

Agency/Funding Organization

NIAID

Funding Year

2016

View Full Project Details